Who owns SILEXION THERAPEUTICS CORP?
- Ticker: SLXN
- CUSIP Number: g1281k130
Tip: Access positions for across all investors
Analyze quarterly positions in Silexion Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silexion Therapeutics Corp stock
Who bought or sold SILEXION THERAPEUTICS CORP this quarter?
There are no current stakeholders of Silexion Therapeutics Corp.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Silexion Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Mar 2026 | 21k | $27k |
| Two Sigma Securities | Mar 2026 | 12k | $15k |
| A. Montag and Associates | Mar 2026 | 3.0k | $3.8k |
| UBS Group | Mar 2026 | 517.00 | $662.018500 |
| Pflug Koory | Mar 2026 | 333.00 | $426.006900 |
| Jones Financial Companies, L.L | Mar 2026 | 26.00 | $32.000800 |
| SBI Securities | Mar 2026 | 20.00 | $26.000000 |